Caricamento...
FFS: an end(point) to our problems in chronic GVHD trials?
In this issue of Blood, Inamoto et al provide encouragement that we are reaching the time where we have a robust endpoint to use in large, randomized clinical trials testing novel agents in chronic graft-versus-host disease (GVHD).(1)
Salvato in:
| Autore principale: | |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
American Society of Hematology
2014
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4141511/ https://ncbi.nlm.nih.gov/pubmed/25147381 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2014-06-579672 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|